2024 Pilot Cohort Letter of Intent submissions have closed

Deadline for submissions: Friday, March 29 at 5:00 PM Mountain Time

This 2024 Pilot Research Funding Announcement (RFA) seeks proposals that will support the translational advancement of promising health innovations. The program supports proof-of-concept and go-to-market strategy activities through milestone-driven funding. Supported innovations may span the spectrum of health outcomes, including therapeutics, preventatives, diagnostics, devices, methods, or research tools that move the needle forward on unmet patient and public health needs. 

RMT-REACH intends to fund four pilot projects with up to $50,000 each in this application cycle. 

Download the Pilot Award RFA

Eligibility: 

• This award is open to faculty, staff, and postdoctoral researchers, graduate students, and undergraduate students; trainees must identify a faculty sponsor
• Eligible Investigators must be affiliated with an academic institution in Montana, Alaska, Idaho, or Wyoming
• Collaborators from external institutions are eligible to apply with an Eligible Investigator 

Applications should focus on explaining how RMT-REACH funds would improve chances of success in translating the innovation into clinical practice. Proposals will be evaluated for both scientific merit and product development potential, with emphasis on the following criteria: 

• Translational potential
• Unmet need (high disease burden/health disparities) and clinical impact
• Research/Development status and planning 

In addition to receiving proof-of-concept funding, an RMT-REACH Project Manager will be assigned to support the recruitment of domain experts for development and advise on strategies to make products widely accessible. Awardees will also have access to an array of experts ranging from regulatory strategy, intellectual property, market analysis, and follow-on, non-dilutive grant development.